Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jan;87(1):66-74.
doi: 10.1007/s12098-019-03119-8. Epub 2019 Dec 10.

Laboratory Approach to Hemolytic Anemia

Affiliations
Review

Laboratory Approach to Hemolytic Anemia

Manu Jamwal et al. Indian J Pediatr. 2020 Jan.

Abstract

Hemolytic anemias are a group of disorders with varied clinical and molecular heterogeneity. They are characterized by decreased levels of circulating erythrocytes in blood. The pathognomic finding is a reduced red cell life span with severe anemia or, compensated hemolysis accompanied by reticulocytosis. The diagnostic workup or laboratory approach for hemolytic anemias is based on methodical step-wise testing which includes red blood cell morphology, hematological indices with increased reticulocyte count along with clinical features of hemolytic anemias. If conventional laboratory tests are unable to detect the underlying cause of hemolysis, genetic testing is recommended. Sanger sequencing along with conventional testing is the most efficient way to diagnose the underlying genetic causes, especially in thalassemias/hemoglobinopathies, if required. However, hemolytic anemias being highly heterogeneous disorders, next-generation sequencing-based screening is rapidly becoming an efficient way to decipher the etiologies where common causes have been excluded.

Keywords: Hemoglobinopathy; Hemolytic anemia; Laboratory investigations; Red cell disorders; Red cell enzyme deficiencies.

PubMed Disclaimer

References

    1. Cytometry B Clin Cytom. 2008 Jul;74(4):244-50 - PubMed
    1. Br J Haematol. 2000 Dec;111(3):924-33 - PubMed
    1. Br J Haematol. 1996 May;93(2):303-10 - PubMed
    1. Int J Lab Hematol. 2013 Jun;35(3):237-43 - PubMed
    1. Clin Chim Acta. 2017 May;468:81-84 - PubMed

MeSH terms

Substances

Supplementary concepts

LinkOut - more resources